{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -0.01, "epsForward": 0.0, "sharesOutstanding": 306436992, "bookValue": -0.003, "fiftyDayAverage": 0.01164, "fiftyDayAverageChange": 0.00035999995, "fiftyDayAverageChangePercent": 0.03092783, "twoHundredDayAverage": 0.03417, "twoHundredDayAverageChange": -0.022170002, "twoHundredDayAverageChangePercent": -0.64881474, "marketCap": 3983676, "priceToBook": -4.0, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "currency": "AUD", "financialCurrency": "AUD", "regularMarketOpen": 0.012, "averageDailyVolume3Month": 439506, "averageDailyVolume10Day": 116920, "fiftyTwoWeekLowChange": 0.0020000003, "fiftyTwoWeekLowChangePercent": 0.20000003, "fiftyTwoWeekRange": "0.01 - 0.065", "fiftyTwoWeekHighChange": -0.052999996, "fiftyTwoWeekHighChangePercent": -0.81538457, "fiftyTwoWeekLow": 0.01, "fiftyTwoWeekHigh": 0.065, "earningsTimestamp": 1682645305, "earningsTimestampStart": 1682645305, "earningsTimestampEnd": 1682645305, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1379548800000, "priceHint": 4, "marketState": "PRE", "regularMarketChange": 0.0, "regularMarketTime": 1683697678, "regularMarketDayHigh": 0.012, "regularMarketDayRange": "0.012 - 0.012", "regularMarketDayLow": 0.012, "regularMarketVolume": 824416, "regularMarketPreviousClose": 0.012, "bid": 0.012, "ask": 0.014, "bidSize": 0, "askSize": 0, "fullExchangeName": "ASX", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.012, "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "esgPopulated": false, "exchange": "ASX", "shortName": "REGENEUS FPO", "longName": "Regeneus Ltd", "messageBoardId": "finmb_244116599", "market": "au_market", "symbol": "RGS.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2 Paddington Street", "city": "Paddington", "state": "NSW", "zip": "2021", "country": "Australia", "phone": "1300 995 098", "fax": "61 2 9357 0711", "website": "https://regeneus.com.au", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Regeneus Ltd, a clinical stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain, and dermatology diseases in Australia. Its lead platform technology includes Progenza, a multi-synergistic therapy for the treatment of osteoarthritis and neuropathic pain. The company also develops Sygenus for the treatment of skin wound healing. Regeneus Ltd was incorporated in 2007 and is headquartered in Paddington, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Karolis  Rosickas", "title": "Chief Exec. Officer", "fiscalYear": 2022, "totalPay": {"raw": 526155, "fmt": "526.15k", "longFmt": "526,155"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Graham  Vesey Ph.D.", "age": 57, "title": "Chief Scientific Officer & Exec. Director", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 120868, "fmt": "120.87k", "longFmt": "120,868"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Charlotte  Morgan Ph.D.", "title": "Head of R&D", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ling Leung Hang", "title": "Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}